Shen H, Luo W, Hu J, Yang J, Song Y, Chen X
Endocrine. 2024; 85(3):1417-1424.
PMID: 39009922
DOI: 10.1007/s12020-024-03885-2.
Jahan S, Yang J, Hu J, Li Q, Fuller P
Endocr Connect. 2024; 13(3).
PMID: 38180077
PMC: 10831533.
DOI: 10.1530/EC-23-0445.
Freitas T, Maciel A, Fagundes G, Petenuci J, Santana L, Guimaraes A
J Endocr Soc. 2023; 8(1):bvad147.
PMID: 38075562
PMC: 10701630.
DOI: 10.1210/jendso/bvad147.
Leung A, Symonds C, Hundemer G, Ronksley P, Lorenzetti D, Pasieka J
Hypertension. 2022; 79(8):1835-1844.
PMID: 35652330
PMC: 9278709.
DOI: 10.1161/HYPERTENSIONAHA.122.19377.
Shen H, Xu Z, Li Q
Chronic Dis Transl Med. 2020; 6(1):1-5.
PMID: 32226929
PMC: 7096326.
DOI: 10.1016/j.cdtm.2019.12.009.
Adrenalectomy for Primary Aldosteronism: Significant Variability in Work-Up Strategies and Low Guideline Adherence in Worldwide Daily Clinical Practice.
Vorselaars W, Van Beek D, Suurd D, Postma E, Spiering W, Borel Rinkes I
World J Surg. 2020; 44(6):1905-1915.
PMID: 32025781
DOI: 10.1007/s00268-020-05408-2.
The characteristics of captopril challenge test-positive patients using various criteria.
Kidoguchi S, Sugano N, Hayashi-Ishikawa N, Morisawa N, Tokudome G, Yokoo T
J Renin Angiotensin Aldosterone Syst. 2019; 20(3):1470320319870891.
PMID: 31434530
PMC: 6709445.
DOI: 10.1177/1470320319870891.
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.
Pizzolo F, Salvagno G, Caruso B, Cocco C, Zorzi F, Zaltron C
J Hum Hypertens. 2017; 31(12):826-830.
PMID: 29115296
DOI: 10.1038/jhh.2017.62.
Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios.
Kim J, Park K, Hong A, Shin C, Kim S, Kim S
Endocrinol Metab (Seoul). 2016; 31(2):277-83.
PMID: 27184013
PMC: 4923412.
DOI: 10.3803/EnM.2016.31.2.277.
Issues in the Diagnosis and Treatment of Primary Aldosteronism.
Burrello J, Monticone S, Buffolo F, Tetti M, Giraudo G, Schiavone D
High Blood Press Cardiovasc Prev. 2015; 23(2):73-82.
PMID: 25854140
DOI: 10.1007/s40292-015-0084-5.
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner I
Semin Nephrol. 2013; 33(3):265-76.
PMID: 23953804
PMC: 3748390.
DOI: 10.1016/j.semnephrol.2013.04.007.
Mineralocorticoid hypertension.
Gupta V
Indian J Endocrinol Metab. 2011; 15 Suppl 4:S298-312.
PMID: 22145132
PMC: 3230101.
DOI: 10.4103/2230-8210.86972.
Primary aldosteronism: from bench to bedside.
Sukor N
Endocrine. 2011; 41(1):31-9.
PMID: 22042487
DOI: 10.1007/s12020-011-9553-3.
Primary aldosteronism: A Japanese perspective.
Satoh F, Morimoto R, Iwakura Y, Ono Y, Kudo M, Takase K
Rev Endocr Metab Disord. 2011; 12(1):11-4.
PMID: 21305358
PMC: 3085751.
DOI: 10.1007/s11154-011-9161-9.
Diagnosis and treatment of primary aldosteronism.
Mulatero P, Monticone S, Veglio F
Rev Endocr Metab Disord. 2011; 12(1):3-9.
PMID: 21279548
DOI: 10.1007/s11154-011-9156-6.
